Specialty Drugs - A Distinctly American Phenomenon

N Engl J Med. 2020 Jun 4;382(23):2179-2181. doi: 10.1056/NEJMp1909513.
No abstract available

MeSH terms

  • Cost Sharing / economics*
  • Cost Sharing / legislation & jurisprudence
  • Cost-Benefit Analysis
  • Drug Costs / legislation & jurisprudence*
  • Drug Industry / legislation & jurisprudence*
  • Government Regulation
  • Humans
  • Insurance Coverage / economics
  • Insurance, Pharmaceutical Services / economics
  • Medicaid / economics
  • Medicare Part D / economics
  • Patient Protection and Affordable Care Act
  • Pharmaceutical Preparations / economics*
  • Rare Diseases / drug therapy
  • United States

Substances

  • Pharmaceutical Preparations